Zijie H. Zhou

1678 Dongfang Road
Dongfang, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Glycosyl Aziridine Carbamates as Versatile Donors for Catalytically Activated Glycosylation.

Glycosyl Aziridine Carbamates as Versatile Donors for Catalytically Activated Glycosylation.

Journal: Angewandte Chemie (International ed. in English)

Published: February 22, 2026

Correction: Fluoride and Cardiovascular Diseases: Epidemiologic Investigations and Mechanistic Insights.

Correction: Fluoride and Cardiovascular Diseases: Epidemiologic Investigations and Mechanistic Insights.

Journal: Biological trace element research

Published: February 11, 2026

A cardiac fibrosis specific circRNA_006640 sponges miR-7648-3p and miR-185-3p to synergistically up-regulate CTGF.

A cardiac fibrosis specific circRNA_006640 sponges miR-7648-3p and miR-185-3p to synergistically up-regulate CTGF.

Journal: Molecular and cellular biochemistry

Published: January 28, 2026

Targeting IL-1α Sensitizes HNSCC to PDT by Reversing Hypoxia and NF-κB-Driven Oxidative Stress Resistance.

Targeting IL-1α Sensitizes HNSCC to PDT by Reversing Hypoxia and NF-κB-Driven Oxidative Stress Resistance.

Journal: International journal of biological sciences

Published: January 08, 2026

Reactivity Tuning by Ring Size: A Glycosylation Protocol Using Thiophene-Scaffolded Glycosyl Donors.

Reactivity Tuning by Ring Size: A Glycosylation Protocol Using Thiophene-Scaffolded Glycosyl Donors.

Journal: Organic letters

Published: December 11, 2025

First-in-human phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors, including recurrent or metastatic HNSCC.

First-in-human phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors, including recurrent or metastatic HNSCC.

Journal: BMC medicine

Published: November 28, 2025

Fluoride and Cardiovascular Diseases: Epidemiologic Investigations and Mechanistic Insights.

Fluoride and Cardiovascular Diseases: Epidemiologic Investigations and Mechanistic Insights.

Journal: Biological trace element research

Published: November 20, 2025

A Nano-Interception Strategy for Chronic Heart Failure: Prussian Blue Nanoparticles Disrupt Fibroblast-Immune Communication via CCL2 Sequestration.

A Nano-Interception Strategy for Chronic Heart Failure: Prussian Blue Nanoparticles Disrupt Fibroblast-Immune Communication via CCL2 Sequestration.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: October 14, 2025

Anthracene-Bridged Detergents for Membrane Protein Studies.

Anthracene-Bridged Detergents for Membrane Protein Studies.

Journal: ChemPlusChem

Published: May 20, 2025

Biomimetic membrane-coating zinc sulfide nanoparticles for anti-inflammatory combined neuroprotective therapy for spinal cord injury.

Biomimetic membrane-coating zinc sulfide nanoparticles for anti-inflammatory combined neuroprotective therapy for spinal cord injury.

Journal: Bioactive materials

Published: February 25, 2025

Copper-Catalyzed Glycosylation Protocol Based on 1,4-Naphthoquinone-Derived Thioglycosides.

Copper-Catalyzed Glycosylation Protocol Based on 1,4-Naphthoquinone-Derived Thioglycosides.

Journal: Organic letters

Published: February 25, 2025

In(OTf)3-Only-Catalyzed Glycosylation via Activation of an Alkyne Appended with an Amide Auxiliary Group.

In(OTf)3-Only-Catalyzed Glycosylation via Activation of an Alkyne Appended with an Amide Auxiliary Group.

Journal: Organic letters

Published: February 10, 2025

Showing 1-12 of 34

Last Updated: 09/26/2026